Cite
Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD.
MLA
de-Torres, Juan P., et al. “Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD.” CHEST, vol. 160, no. 3, Sept. 2021, pp. 872–78. EBSCOhost, https://doi.org/10.1016/j.chest.2021.04.033.
APA
de-Torres, J. P., O’Donnell, D. E., Marín, J. M., Cabrera, C., Casanova, C., Marín, M., Ezponda, A., Cosio, B. G., Martinez, C., Solanes, I., Fuster, A., Neder, J. A., Gonzalez-Gutierrez, J., Celli, B. R., O’Donnel, D. E., Neder, A., & Gutierrez, J. G. (2021). Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD. CHEST, 160(3), 872–878. https://doi.org/10.1016/j.chest.2021.04.033
Chicago
de-Torres, Juan P., Denis E. O’Donnell, Jose M. Marín, Carlos Cabrera, Ciro Casanova, Marta Marín, Ana Ezponda, et al. 2021. “Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD.” CHEST 160 (3): 872–78. doi:10.1016/j.chest.2021.04.033.